Alkermes Announces Positive Results For Phase 1 Study Of New Drug Candidate For Treatment Of Opioid-Induced Constipation

Links shared publicly online about this topic.

  • 1,373
    total visits

Alkermes Announces Positive Results For Phase 1 Study Of New Drug Candidate For Treatment Of Opioid-Induced Constipation

medicalnewstoday.com —

Alkermes, Inc. (NASDAQ: ALKS) announced positive topline data from a phase 1 clinical study of ALKS 37, an orally active, peripherally-restricted opioid antagonist with potential to block the effe

View full resource at medicalnewstoday.com

Tags: Constipation, Drug, Phase 1 Clinical Trial

  • Share

Most Recently Shared on February 19, 2010 at 9:04 am By:

LifelineProject Lifeline

RT @healthytweet: Phase 1 Study Of New Drug Candidate For Treatment Of Opioid induced constipation | http://bit.ly/ao7Sbd

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

MNT Gastrointestinal MNT Gastrointestinal

MNT Clinical Trials MNT Clinical Trials

MNT Pain News MNT Pain News

Advertisement